Enko Welcomes Tim Hassinger as the Company’s Newest Board Member

Tim Hassinger, CEO, President, and Chairman of the board of directors, Intelinair (Indianapolis), has joined Enko Chem, Inc., as the agricultural discovery company’s newest board member.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240724249811/en/

Tim Hassinger, CEO, President, and Chairman of the board of directors, Intelinair, has joined Enko Chem, Inc., as the agricultural discovery company’s newest board member. (Photo: Business Wire)

Hassinger brings nearly forty years of experience in the agricultural industry. Prior to being named CEO and President of Intelinair in January 2022, he was CEO of Dow AgroSciences, the Indianapolis-based agricultural subsidiary of The Dow Chemical Company, where he had held crop protection, commercial sales, supply chain, marketing, and management roles over 33 years. He then moved to become CEO at Lindsay Corporation in Omaha, Neb.

Intelinair, Hassinger’s current firm, provides whole field insights via hi-res aerial imagery and machine learning, to inform agronomic management decisions via its interactive AGMRI platform. He also currently serves on the Board of Directors of AGDATA and Hatch for Hunger.

Tim Hassinger said: “I am looking forward to working with Enko’s accomplished team and contributing to the strategic plan for the next phase of the company. I am impressed by the speed of the R&D, the results, and Enko’s potential to bring sustainable farm outputs around the globe.”

Marijn Dekkers, Chairman of Enko and Chairman of Novalis LifeSciences, commented: “We are very excited to have Tim join our board. His wide global ag perspective will be invaluable in helping Enko in its development of novel data-driven products for farmers to protect their crops from pests, weeds and disease.”

About Enko®

Enko (Enko Chem Inc.) designs safe and sustainable solutions to farmers’ biggest crop threats today, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers’ evolving needs. Founded in 2017, and led by a team of proven scientists, entrepreneurs, and agriculture industry veterans, Enko is backed by investors including the Bill & Melinda Gates Foundation, Anterra Capital, Finistere Ventures, Nufarm, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund. Enko is headquartered in Mystic, Connecticut, USA. For more information, visit www.enko.ag

Enko’s Cautionary Statement Regarding Forward-Looking Statements

This press release contains forecasts, projections, goals, plans, and other forward-looking statements. Such forward-looking statements are based on Enko's assumptions, estimates, outlook, and other judgments made in light of information available at the time of preparation of such statements and involve both known and unknown risks and uncertainties. Accordingly, plans, goals, and other statements may not be realized as described, and actual financial results, success/failure or progress of development, and other projections may differ materially from those presented herein. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Enko’s control and that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Enko does not intend to update any forward-looking statements appearing herein in the event of changing circumstances or otherwise, and such statements are current only as of the date they are made.

©Enko Chem, Inc., 62 Maritime Drive, Mystic, CT 06355 USA

View source version on businesswire.com: https://www.businesswire.com/news/home/20240724249811/en/